These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13092058)

  • 21. Efficacy of fresh-frozen plasma and cryoprecipitate in dogs with von Willebrand's disease or hemophilia A.
    Stokol T; Parry B
    J Vet Intern Med; 1998; 12(2):84-92. PubMed ID: 9560764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombelastographic observations on the characteristics of hemophilic, thrombocytopenic and heparinized blood.
    DE NICOLA P; MAZZETTI GM
    Blood; 1956 Jan; 11(1):71-80. PubMed ID: 13276486
    [No Abstract]   [Full Text] [Related]  

  • 23. Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.
    Brinkhous KM; Sandberg H; Garris JB; Mattsson C; Palm M; Griggs T; Read MS
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8752-6. PubMed ID: 3936044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.
    Cooper HA; Wagner RH
    J Clin Invest; 1974 Nov; 54(5):1093-9. PubMed ID: 4213756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Appearance of an antithrombin following thrombin injections in a hemophilic having presented a circulating anticoagulant].
    SOULIER JP
    Rev Hematol; 1953; 8(1):39-43. PubMed ID: 13101088
    [No Abstract]   [Full Text] [Related]  

  • 26. [Research on the antithromboplastin factors in hemophilia. 1. The plasma antithromboplastin of Tocantins].
    CHEVALLIER P; FIEHRER A; BILSKI-PASQUIER G; SAMAMA M
    Sang; 1955; 26(4):362-76. PubMed ID: 13246570
    [No Abstract]   [Full Text] [Related]  

  • 27. The relation of certain fractions of the plasma globulins to the coagulation defect in hemophilia.
    LEWIS JH; TAGNON HJ
    Blood; 1946 Mar; 1():166-72. PubMed ID: 21015979
    [No Abstract]   [Full Text] [Related]  

  • 28. Clotting defect in hemophilia; deficiency in a plasma factor required for thromboplastin liberation from platelets.
    BRINKHOUS KM
    Fed Proc; 1947; 6(1):389. PubMed ID: 20343817
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that glass increases plasma PTA activity.
    RAPAPORT SI
    J Lab Clin Med; 1958 Oct; 52(4):624-33. PubMed ID: 13588175
    [No Abstract]   [Full Text] [Related]  

  • 31. [Factor VIII (anti-hemophilic A factor). Biology, physiology, pathology and genetics].
    Meyer D; Dray L; Allain JP; Larrieu MJ
    Pathol Biol (Paris); 1972; 20(11):607-23. PubMed ID: 4558579
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombokinetic studies in normal and factor VIII-deficient canine plasmas.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):157-62. PubMed ID: 6603892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibitory effect of haemophilic plasma.
    BIGGS R
    Br J Haematol; 1958 Apr; 4(2):192-200. PubMed ID: 13536256
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical, clinical and immunological studies on the products of human plasma fractionation; the coagulation defect in hemophilia; the effect in vitro and in vivo on the coagulation time in hemophilia of a prothrombin and fibrinogen-free normal plasma and its derived protein fractions.
    LEWIS JH; SOULIER JP; TAYLOR FH
    J Clin Invest; 1946 Nov; 25(6):876-9. PubMed ID: 20282730
    [No Abstract]   [Full Text] [Related]  

  • 36. Electrophoretic plasma protein patterns in families with hemophilia.
    BERNFELD P; STEFANINI M; BERKOWITZ RD; HENNESSEY FB
    Proc Soc Exp Biol Med; 1953 Jun; 83(2):311-5. PubMed ID: 13064254
    [No Abstract]   [Full Text] [Related]  

  • 37. Assay of plasma antihemophilic activity in normal heterozygous (hemophilia) and prothrombinopenic dogs.
    GRAHAM JB; COLLINS DL; GODWIN ID; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1951 Jun; 77(2):294-6. PubMed ID: 14854025
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma antihemophilic factor biological and clinical aspects.
    BRINKHOUS KM
    Sang; 1954; 25(7):738-41. PubMed ID: 13225559
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.
    Turecek PL; Gritsch H; Richter G; Auer W; Pichler L; Schwarz HP
    Thromb Haemost; 1997 Mar; 77(3):591-9. PubMed ID: 9066015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.